Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Mesothelioma, photodynamic therapy

Recently, the first experimental clinical investigation on the local use of hypericin 1 as photosensitizer for photodynamic therapy in a patient with recurrent malignant mesothelioma has been reported [170]. A phase I clinical trail utilizing orally administrated hypericin 1 in patients harboring recurrent malignant gliomas is ongoing [146]. A review on the use of hypericin 1 in adjuvant brain tumor therapy has lately been published [146]. [Pg.678]

S.L. Gibson, T.H. Foster, R.H. Feins, R.F. Raubertas, M.A. Fallon, R. Hilf (1994). Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Br. J. Cancer, 69, 473-481. [Pg.46]

Brophy PF, Keller SM. Adriamycin enhanced in vitro and in vivo photodynamic therapy of mesothelioma. J Surg Res 52 631-634 (1992). [Pg.122]

Schouwink, H., Ruevekamp, M., Oppelaar, H., van Veen, R., Bass, R, and Stewart, F.A., Photodynamic therapy for malignant mesothelioma prechnical studies for optimization of treatment protocols, Photochem. PhotobioL, 73,410, 2001. [Pg.2822]

See other pages where Mesothelioma, photodynamic therapy is mentioned: [Pg.1036]    [Pg.49]    [Pg.2858]    [Pg.298]   
See also in sourсe #XX -- [ Pg.10 ]



SEARCH



Photodynamic therapy

© 2024 chempedia.info